- Home
- BODI vs ITRM Comparison
BODI vs ITRM Comparison
Compare BODI & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BODI
- ITRM
- Stock Information
- Founded
- BODI 1998
- ITRM 2015
- Country
- BODI United States
- ITRM Ireland
- Employees
- BODI N/A
- ITRM N/A
- Industry
- BODI Industrial Machinery/Components
- ITRM Biotechnology: Pharmaceutical Preparations
- Sector
- BODI Industrials
- ITRM Health Care
- Exchange
- BODI Nasdaq
- ITRM Nasdaq
- Market Cap
- BODI 46.9M
- ITRM 40.0M
- IPO Year
- BODI N/A
- ITRM 2018
- Fundamental
- Price
- BODI $4.24
- ITRM $0.59
- Analyst Decision
- BODI Buy
- ITRM Strong Buy
- Analyst Count
- BODI 2
- ITRM 1
- Target Price
- BODI $10.00
- ITRM $9.00
- AVG Volume (30 Days)
- BODI 13.8K
- ITRM 825.4K
- Earning Date
- BODI 11-10-2025
- ITRM 11-12-2025
- Dividend Yield
- BODI N/A
- ITRM N/A
- EPS Growth
- BODI N/A
- ITRM N/A
- EPS
- BODI N/A
- ITRM N/A
- Revenue
- BODI $324,871,000.00
- ITRM N/A
- Revenue This Year
- BODI N/A
- ITRM N/A
- Revenue Next Year
- BODI N/A
- ITRM $482.25
- P/E Ratio
- BODI N/A
- ITRM N/A
- Revenue Growth
- BODI N/A
- ITRM N/A
- 52 Week Low
- BODI $3.38
- ITRM $0.57
- 52 Week High
- BODI $8.71
- ITRM $3.02
- Technical
- Relative Strength Index (RSI)
- BODI 29.27
- ITRM 34.47
- Support Level
- BODI $4.61
- ITRM $0.64
- Resistance Level
- BODI $5.20
- ITRM $0.70
- Average True Range (ATR)
- BODI 0.39
- ITRM 0.04
- MACD
- BODI -0.10
- ITRM -0.01
- Stochastic Oscillator
- BODI 10.52
- ITRM 9.24
About BODI The Beachbody Company Inc. Class A Common Stock
The Beachbody Co Inc is a health and wellness platform providing fitness, nutrition and stress-reducing programs to its customers. The product offerings of the company include Digital Subscriptions, Nutritional Products, and Connected Fitness Products. It earns the majority of its revenue from the United States. The company operates and manages its business in one operating segment. Majority of revenue is through Digital.
About ITRM Iterum Therapeutics plc
Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.